Therapeutic proteins from nice bacteria combat infection

A new immunotherapeutic agent, produced by ‘’nice’’ bacteria, has shown significant therapeutic potential against bacterial infections.A publication describing these findings is now available online (doi:10.1172/JCI140333 ). The Journal of Clinical Investigation is one of the top journals in the Medicine, Research & Experimental Web of Science category and publishes international discoveries with clinical relevance. SelectImmune Pharma is developing this new immunotherapeutic agent for clinical trials. The scientists at Lund University have